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Abstract
Catel-Manzke syndrome, also known as micrognathia-digital-syndrome, is a rare autoso-
mal recessive disorder characterized by the combination of the two cardinal features
Pierre-Robin sequence and bilateral hyperphalangy leading to ulnar clinodactyly (ulnar
curvature of the phalanges) and radial deviation (radial angulation at the
metacarpophalangeal joint) of the index fingers. Individuals without one of these major
hallmarks or with additional hand malformations have been described as atypical or
Catel-Manzke-like syndrome. Biallelic TGDS pathogenic variants have thus far been
detected in eight individuals with typical Catel-Manzke syndrome and in one fetus with
additional features. Here we report on two individuals with TGDS pathogenic variants
who presented with mild radial deviation and ulnar clinodactyly of the index fingers but
without radiologic signs of hyperphalangy. Furthermore, both individuals have dispro-
portionate short stature, a feature that has not yet been associated with Catel-Manzke
syndrome. Our data broaden the phenotypic spectrum of TGDS-associated Catel-
Manzke syndrome and expand the indication for diagnostic testing.
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1 | INTRODUCTION
Catel-Manzke syndrome, also known as micrognathia-digital-syndrome
(MIM:616145), is characterized by the combination of the two cardinal
features Pierre-Robin sequence (with or without cleft palate) and
bilateral hyperphalangy leading to ulnar clinodactyly (ulnar curva-
ture of the phalanges), radial deviation (radial angulation at the
metacarpophalangeal joint), and shortening of the index finger
(Catel & Heintzen, 1963). Hyperphalangy (also referred to as
Manzke dysostosis) is caused by an accessory ossification center
between the proximal phalanx and metacarpal (Manzke, 1966). The
supernumerary phalanx coalesces with the proximal phalanx with
age. Additional congenital abnormalities comprise congenital heart
defects, joint hypermobility, mild facial dysmorphism, pectus defor-
mities, short halluces, and fifth finger clinodactyly (Manzke,
Lehmann, Klopocki, & Caliebe, 2008). Pierre-Robin sequence and
congenital heart defects can lead to postnatal failure to thrive and
cause severe morbidity and an increased mortality. Biallelic patho-
genic variants in TGDS have been described in nine individuals
including one fetus with Catel-Manzke syndrome (Ehmke et al.,
2014; Pferdehirt, Jain, Blazo, Lee, & Burrage, 2015; Schoner et al.,
2017). Individuals without one of the two major hallmarks or withFelix Boschann and Kyra E. Stuurman contributed equally to this study.
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additional hand malformations have been described as atypical or
Catel-Manzke-like syndrome (Manzke et al., 2008). Although TGDS
pathogenic variants were detected in a fetus with additional short-
ening of the middle fingers (Schoner et al., 2017), and IMPAD1
pathogenic variants were detected in two other individuals with
Catel-Manzke-like syndrome (Nizon, Alanay, et al., 2012), the
genetic cause remains unknown in the majority of atypical cases.
We report on two individuals with known TGDS pathogenic vari-
ants who presented with mild bilateral radial deviation and ulnar
clinodactyly of the index fingers but without radiological signs of
hyperphalangy. In addition, both individuals have disproportionate
short stature, which extends the known phenotypic spectrum.
2 | MATERIAL AND METHODS
The parents gave their written consent for genetic testing and the
publication of clinical information and photographs. Trio exome
sequencing for both individuals was performed at GenomeScan
(Leiden, The Netherlands) as described previously (Popov et al., 2019).
3 | RESULTS
3.1 | Clinical report
Individual 1 was born at term as the second child of non-
consanguineous Dutch parents with an unremarkable family history
with a birth weight of 3,680 g (+0.38 SD), a length of 48 cm
(−1.78 SD), and a HC of 35 cm (−0.02 SD). On prenatal ultrasound,
short limbs were seen as well as retrognathia for which amniocen-
tesis was performed. Karyotyping did not show any abnormalities.
Shortly after birth, Pierre-Robin sequence with cleft palate, radial
deviation and ulnar clinodactyly of both index fingers was noted.
Six weeks postpartum her body length was 51.8 cm (−2 SD). She
developed a more pronounced pectus excavatum deformity during
her first year of life and joint laxity became apparent. At the age of
13 months, surgery for correction of her cleft palate was per-
formed, and she received exercise treatment for her phalangeal
deformities. However, she developed a bilateral hip dysplasia for
which she received bilateral femoral osteotomy at the age of
9 years. Her psychomotor development progressed normally. Her
sitting height to height ratio at the age of 10 years was 0.575
(+4.6 SD). At last physical examination at the age of 13 years her
height was 131 cm (−4.4 SD). Parental heights were 182.2 and
169.6 cm for her father and mother, respectively, therefore decid-
ing her target height at 169.7 cm. She also presented with craniofa-
cial features including thin arched eyebrows, mild hypertelorism,
proptosis, low-set posteriorly rotated ears, full cheeks, and small
mouth. Hand radiographs taken over the years showed no signs of
hyperphalangy (Figure 1f–h). Extensive genetic testing single nucle-
otide polymorphism (SNP) array, NGS panel including Stickler syn-
drome associated genes because of her joint hypermobility and
cleft palate, and next generation sequencing (NGS) panel including
genes associated with connective tissue disorders due to her
hypermobility) did not show any abnormalities.
Individual 2 is the first child of healthy, non-consanguineous par-
ents with an unremarkable family history. Parents had a previous his-
tory of two first-trimester miscarriages at 5 and 6 weeks of gestation
prior to this pregnancy. Prenatal ultrasound showed a short femur,
and chromosome analysis after amniocentesis revealed a 46,XY karyo-
type. The boy was delivered in the 41st week of pregnancy with a
birth weight of 3,610 g (−0.21 SD) and a length of 47 cm (−2.58 SD).
Postnatal he was noted to have retrognathia, low-set ears, ptosis,
short neck, thin eyebrows (Figure 1a), and bilateral hand abnormali-
ties. During the first months of life, he had chronic lung problems due
to paralysis of the right-side diaphragm. No abnormalities were
detected on cardiac ultrasound. Over the years, he developed pro-
gressive short stature (Figure 1b) for which extensive endocrine
labs, genetic evaluation (SNP array, sequencing and mulitplex
ligation-dependent probe amplification (MLPA) analysis of SHOX)
and skeletal surveys were performed, but no causal diagnosis was
ever made. He was otherwise healthy with normal neuro-
development, milestones and above-average school performances.
He did undergo corrective surgery for positional deformity of his
knees (genu valgus) and was frequently seen by an orthodontist
due to malar crowding and retrognathia. When last seen in clinic at
the age of 15 years, he had short stature with a height of 154 cm
(−2.7 SD) with a mid-parental height of −0.5 SD. His weight for
height was normal (+1.0 SD), as were his head circumference of
53.5 cm (−1.4 SD) and arm span of 157 cm. He did have dispropor-
tionately short legs with a sitting height to height ratio of 0.552
(+3.8 SD). On physical exam, he was noted to have retrognathia,
low-set ears, high palate, and a bifid uvula (Figure 1c,d). Mild radial
deviation and ulnar clinodactyly of both index fingers was present
(Figure 1i). In addition, he had remarkable muscularity of both
upper legs and calves without a history of frequent weight training.
Tanner stage was V with testicular volume of 20 ml bilateral. Hand
radiographs performed over the years showed mild ulnar
clinodactyly and radial deviation of the index finger but no hyper-
phalangy (Figure 1j–l).
Clinical features of the two individuals and all previously reported
individuals with confirmed TGDS pathogenic variants are summarized
in Table 1.
3.2 | Genotype
Trio exome sequencing of Individual 1 and her parents showed the
homozygous missense variant c.700T>C, p.(Tyr234His) in exon 9 of
TGDS (chr13[GRCh37]:g.95230384A>G; NM_014305.3). We also
detected a de novo heterozygous 1-bp duplication in HYDIN
(NM_001270974.2; c.13228_13229dup, p.(Thr4411fs)). Biallelic
HYDIN pathogenic variants cause primary ciliary disease (PCD). A
second variant in HYDIN was not found and the individual does not
have any features of PCD. Therefore, she is most likely a carrier of
PCD. In addition, we found a maternally inherited known pathogenic
variant in IMPG2 (NM_016247.3; c.2716C>T, p.(Arg906*)). Biallelic
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IMPG2 pathogenic variants cause Retinitis Pigmentosa (RP), which
has not been reported in the maternal family. A second variant in
IMPG2 was not found and the individual does not have any features
of RP. Therefore, she is most likely a carrier of RP.
Trio exome sequencing of Individual 2 and his parents showed com-
pound heterozygosity for the paternally inherited variant c.700T>C,
p.(Tyr234His) in exon 9 of TGDS (chr13[GRCh37]:g.95230384A>G) and
the maternally inherited variant c.298G>T, p.(Ala100Ser) in exon 4 of
TGDS (chr13[GRCh37]:g.95243122C>A).
In both individuals, no other variants in genes associated with
short stature were identified.
4 | DISCUSSION
The two individuals described here are the first with confirmed TGDS
pathogenic variants who present with almost normal hand radiographs
and therefore do not show one of the clinical hallmarks of Catel-
Manzke syndrome, that is, Manzke dysostosis (Manzke, 1966). Until
now, nine individuals (including one fetus) with biallelic TGDS patho-
genic variants have been reported (Ehmke et al., 2014; Pferdehirt
et al., 2015; Schoner et al., 2017). All individuals presented with
Pierre-Robin sequence and hyperphalangy; only in the fetus shorten-
ing of the proximal second and third phalangeal bone was detected
but no hyperphalangy, which could be due to the early time point of
imaging (22nd week of gestation) (Schoner et al., 2017). Both individ-
uals presented in this study have mild bilateral radial deviation and
ulnar clinodactyly of the index fingers (Figure 1e,i), despite the
absence of hyperphalangy or shortening of the proximal phalanx on
hand radiographs. In Individual 1, an additional clinodactyly of the
digits and V is visible (Figure 1e). Thus, our findings demonstrate that
the clinical manifestation of the “digital” phenotype varies greatly
(i.e., bilateral hyperphalangy of the second fingers, shortening of the
second and third fingers, or no signs of hyperphalangy or shortening
on radiographs). Likewise, not all individuals show the full spectrum of
Pierre-Robin sequence (i.e., micro−/retrognathia, glossoptosis, and
cleft palate). Until now, the presence of the two main hallmarks
micro-/retrognathia and hyperphalangy provided the basis for the
phenotypic classification of individuals into typical (classic Catel-
Manzke syndrome) and atypical (Catel-Manzke-like syndrome). It can
be discussed whether this clinical categorization is still reasonable or
whether a molecular genetic classification appears more appropriate
(i.e., TGDS-associated Catel-Manzke syndrome).
TGDS encodes the enzyme thymidine diphosphate (TDP) glucose-
4,5-dehydratase whose function in mammals is still unknown. So far,
seven different pathogenic variants in TGDS have been published
(Ehmke et al., 2014; Pferdehirt et al., 2015; Schoner et al., 2017). Indi-
vidual 1 is homozygous for the variant c.700T>C, p.(Tyr234His), which
has been reported in compound heterozygous state in another Dutch
family (Ehmke et al., 2014; Kant et al., 1998). She presented with
retrognathia and cleft palate, and her facial appearance is similar to the
Individual 2 reported by Ehmke et al. (2014) and the individual reported
by Pferdehirt et al. (2015). Individual 2 in this report carries the above
mentioned variant c.700T>C, p.(Tyr234His) and the most common vari-
ant c.298G>A, p.(Ala100Ser). He has retrognathia and dysmorphic facial
features including low-set ears, thin eyebrows, mild hypertelorism, and
ptosis, all features that have been described in previously reported indi-
viduals. The detection of already known variants in the here reported
individuals despite the nonoccurrence of hyperphalangy on hand radio-
graphs indicates that there is no clear genotype–phenotype correlation.
Furthermore, both individuals in this report have disproportionate short
stature (Individual 1: −4.4 SD for height with a +4.6 SD sitting height to
height ratio, Individual 2: −2.7 SD for height with a +3.8 SD sitting
height to height ratio; Figure 1b). Shortening of the femur was
detected in both individuals on prenatal ultrasound. Four of the
previously reported individuals with confirmed TGDS pathogenic
variants had short stature but our findings show that more severe,
disproportionate short stature are clinical features of TGDS-
associated Catel-Manzke syndrome. Once again, the phenotypic
overlap with the following conditions Desbuquois dysplasia
1 (DBQD1, MIM:251450) caused by pathogenic variants in CANT1
(MIM:613165), Temtamy preaxial brachydactyly syndrome
(MIM:605282) caused by pathogenic variants in CHSY1
(MIM:601882) and chondrodysplasia with joint dislocations
F IGURE 1 Clinical manifestations of Individual 1 (I-1) and 2 (I-2).
(a–d) Clinical photographs of Individual 2 showing thin eyebrows,
ptosis, mild hypertelorism, low-set posteriorly rotated ears, micro
−/retrognathia, short neck, and disproportionately short legs. (e–h)
Clinical photograph and hand radiographs of Individual 1 showing
clinodactyly of digits II, IV, and IV. No radiologic sign of an additional
ossification center is visible. (i–l) Clinical photograph and hand
radiographs of Individual 2 showing bilateral mild radial deviation and
clinodactyly of the index fingers but no sign of Manzke dysostosis
[Color figure can be viewed at wileyonlinelibrary.com]
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(GPAPP deficiency, MIM:614078) caused by pathogenic variants in
IMPAD1 (MIM:614010; Huber et al., 2009; Li et al., 2010; Vissers
et al., 2011) becomes evident. Especially in GPAPP deficiency and
DBQD1 disproportionate short stature is a typical feature (Faivre
et al., 2004; Vissers et al., 2011). These conditions are caused by
defects in proteoglycan metabolism, and it has been proposed that
TGDS also plays a role in this pathway (Ehmke et al., 2014;
Kitagawa, Uyama, & Sugahara, 2001; Moriarity et al., 2002; Nizon,
Huber, et al., 2012; Vissers et al., 2011).
Overall, the phenotypic spectrum of TGDS-associated Catel-
Manzke syndrome seems to be broader than previously assumed
and clinical features can vary from one person to another, even
though they harbor the same pathogenic variants. In summary, TGDS-
associated Catel-Manzke syndrome should be considered in individ-
uals with mild ulnar clinodactyly and radial deviation of the index
fingers even without radiological evidence of an accessory bone and
especially if the combination of micro-/retrognathia and (dispropor-
tionate) short stature is present.
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